Modern heart failure treatment is superior to conventional treatment across the left ventricular ejection spectrum: real-life data from the Swedish Heart Failure Registry 2013-2020.
現代心衰竭治療在左心室射血分數範圍內優於傳統治療:來自瑞典心衰竭登記處2013-2020年的實際數據。
Clin Res Cardiol 2024-08-26
Reno-protective Effects of Empagliflozin in High Fat Diet Induced Obesity-Related Glomerulopathy by Regulation of Gut-Kidney Axis.
高脂飲食誘導的肥胖相關腎小球病中,Empagliflozin 的腎保護作用:透過調節腸腎軸。
Am J Physiol Cell Physiol 2024-08-26
Multimodal fusion learning for long QT syndrome pathogenic genotypes in a racially diverse population.
多模態融合學習於種族多樣性人群中長QT綜合症致病基因型的研究。
NPJ Digit Med 2024-08-24
Dapagliflozin-induced abnormal uterine bleeding in a patient with dilated cardiomyopathy and chronic heart failure: a case report.
Dapagliflozin 引起的異常子宮出血於一名擴張型心肌病及慢性心衰竭患者:病例報告。
J Int Med Res 2024-08-24
Racial Comparison of the Pharmacokinetics and Safety of Fixed-Dose Combination of Dapagliflozin/Sitagliptin in Western and Korean Healthy Adults.
西方與韓國健康成人中 Dapagliflozin/Sitagliptin 固定劑量聯合用藥的藥物動力學及安全性之種族比較。
Clin Ther 2024-08-23
Cost-effectiveness of empagliflozin in the treatment of Malaysian patients with chronic heart failure and preserved or mildly reduced ejection fraction.
empagliflozin 在治療馬來西亞慢性心衰竭及保留或輕度降低射血分數患者中的成本效益分析。
PLoS One 2024-08-23